Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.897 USD | -0.31% | -3.64% | -35.52% |
26/04 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
27/03 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.52% | 173M | |
+8.67% | 105B | |
-0.88% | 104B | |
+5.79% | 22.94B | |
-12.50% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.25% | 16.96B | |
+8.15% | 14.16B | |
+39.51% | 12.63B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Berenberg Bank Adjusts Bluebird Bio's Price Target to $11 From $21, Maintains Hold Rating